Interpretation of the efficacy evaluation of the newly published "the guiding principles of clinical research on the treatment of stroke in new traditional Chinese medicine"SHI Jin, WANG Ke-hua973-975
Flexible clauses in the TRIPS agreement and access to essential medicine from the perspectives of global health governanceWANG Dan, ZHAO Ying-xi, TANG Kun976-984
Impact of data integrity on GMP inspection of Chinese pharmaceutical manufacturersZHANG Tie-jun, HAN Wen-tao, HAN Jing985-989
Research and enlightenment on the drug clinical trial transparency systemYANG Li, TIAN Li-juan, LIN Lin990-998
Inhibitory effects of aconitine, mesaconitine and hypaconitine on cytochrome P4503A4LI Han, WANG Yu-guang, MA Zeng-chun, TAN Hong-ling, XIAO Cheng-rong, TANG Xiang-lin, ZHANG Bo-li, GAO Yue999-1004
Research progress of puerarin in the treatment of experimental liver injury赵月蓉, 侯碧玉, 张莉, 杜冠华, 管淑玉1005-1010
Ferric carboxymaltose and its application in iron deficiency anemiaWANG Fang-hai, ZHAO Wei, CHEN Jian-fang, TANG Wei-fang, QIN Yong1011-1015
Research progress in PCSK9 and lipid lowering drugsZHANG Wei, ZHOU Bing-yang, GUO Yuan-lin, LI Jian-jun1016-1023
Research progress in visualization of alginate embolic microspheres and being as drug carriersZHOU Yi, LI Xu-feng, TAN Lu, WANG Ping, ZHOU Yan-ping, WEI Min-yan, LI Xin, DU Ling-ran1024-1028